ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.320
-0.020 (-1.49%)
Jun 9, 2026, 4:00 PM EDT - Market closed
ABVC BioPharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | 0.51 | 0.15 | 0.97 | 0.36 | |
Revenue Growth (YoY) | - | - | 234.31% | -84.28% | 172.57% | -26.34% |
Cost of Revenue | - | - | 0 | 0.3 | 0.29 | 0.01 |
Gross Profit | - | - | 0.51 | -0.15 | -0.68 | 0.35 |
Selling, General & Admin | 3.02 | 2.89 | 2.26 | 5.37 | 6.07 | 5.75 |
Research & Development | 0.13 | 0.12 | 0.18 | 1.06 | 2.69 | 1 |
Other Operating Expenses | 4.88 | 4.14 | 2.77 | 0.19 | 7.04 | 5.31 |
Total Operating Expenses | 8.03 | 7.15 | 5.21 | 6.62 | 15.8 | 12.06 |
Operating Income | -8.83 | -7.15 | -4.71 | -6.77 | -15.11 | -11.71 |
Interest Income | 0.15 | 0.17 | 0.09 | 0.19 | 0.19 | 0.04 |
Interest Expense | -0.24 | -0.42 | -0.83 | -1.31 | -0.29 | -0.23 |
Other Non-Operating Income (Expense) | -0.16 | -0.95 | 0.07 | -0.13 | -0.29 | 0.68 |
Total Non-Operating Income (Expense) | -0.25 | -1.2 | -0.66 | -1.26 | -0.4 | 0.5 |
Pretax Income | -9.1 | -8.35 | -5.37 | -8.02 | -15.51 | -11.21 |
Provision for Income Taxes | 0.02 | 0.02 | -0.11 | 0.26 | 0.8 | 0.83 |
Net Income | -9.92 | -8.38 | -5.26 | -8.28 | -16.31 | -12.04 |
Minority Interest in Earnings | -0.5 | -0.47 | -0.36 | -0.49 | 0.11 | 0.8 |
Net Income to Common | -9.42 | -7.91 | -4.9 | -7.79 | -16.42 | -12.84 |
Shares Outstanding (Basic) | 23 | 20 | 12 | 4 | 3 | 3 |
Shares Outstanding (Diluted) | 23 | 20 | 12 | 4 | 3 | 3 |
Shares Change (YoY) | 75.00% | 72.25% | 169.81% | 36.64% | - | 60.61% |
EPS (Basic) | -0.39 | -0.39 | -0.42 | -1.80 | -5.19 | -0.51 |
EPS (Diluted) | -0.39 | -0.39 | -0.42 | -1.80 | -5.19 | -0.51 |
Free Cash Flow | -3.34 | -2.99 | -1.81 | -4.21 | -7.52 | -7.62 |
Free Cash Flow Per Share | -0.15 | -0.15 | -0.15 | -0.97 | -2.37 | -2.40 |
Gross Margin | - | - | 99.85% | -98.15% | -70.47% | 98.57% |
Operating Margin | - | - | -923.34% | -4439.24% | -1558.54% | -3290.07% |
Profit Margin | - | - | -1032.02% | -5432.56% | -1682.06% | -3382.79% |
FCF Margin | - | - | -355.02% | -2760.64% | -775.23% | -2140.33% |
EBITDA | -8.8 | -7.13 | -4.67 | -6.74 | -15.09 | -11.69 |
EBITDA Margin | - | - | -917.06% | -4420.52% | -1556.08% | -3286.70% |
EBIT | -8.83 | -7.15 | -4.71 | -6.77 | -15.11 | -11.71 |
EBIT Margin | - | - | -923.34% | -4439.24% | -1558.54% | -3290.07% |
Effective Tax Rate | -0.27% | -0.29% | 2.06% | -3.19% | -5.14% | -7.36% |